Neurology
4 drugs are in development for Amyotrophic Lateral Sclerosis.
- Companies
- 3
- Clinical trials
- 35
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Amyotrophic Lateral Sclerosis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(2)
Phase 2(1)
| Drug | Company |
|---|---|
| cnm-au8 | Clene Inc. (CLNN) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| amt-162 | uniQure N.V. (QURE) |
About this indication
Amyotrophic Lateral Sclerosis context
Neurology·MeSH: Amyotrophic Lateral Sclerosis (D000690)
Also known as: ALS Amyotrophic Lateral Sclerosis, Charcot Disease, Disease, Lou-Gehrigs, Gehrig Disease, Gehrigs Disease, Lou Gehrig Disease, Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Incidence
2.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Amyotrophic Lateral Sclerosis?
BioSniper tracks 4 drugs in development for Amyotrophic Lateral Sclerosis across 3 companies.
How many clinical trials target Amyotrophic Lateral Sclerosis?
There are 35 clinical trials targeting Amyotrophic Lateral Sclerosis tracked by BioSniper.